Modulation of peripheral chemoreflex by neurohumoral adaptations after kidney transplantation

European Journal of Medical Research

Volumn 15, Issue 2, 2010, Pages 83-87

  Rassaf, T ^a   Westenfeld, R ^a   Balzer, J ^a   Lauer, T ^a   Merx, M ^a   Floege, J ^a   Steiner, S ^a   Heiss, C ^a   Kelm, M ^a   Meyer, Christian ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

autonomic; chemoreflexes; end stage renal disease; nervous system

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; OXYGEN; TACROLIMUS;

ADULT; ARTICLE; CHEMORECEPTOR REFLEX; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART RATE VARIABILITY; HEMODIALYSIS; HUMAN; HYPEROXIC CHEMOREFLEX SENSITIVITY; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; NEUROHUMORAL MODULATION; NEUROMODULATION; OXYGEN TENSION; RR INTERVAL; SYMPATHETIC TONE; ADAPTATION; ADRENERGIC SYSTEM; CHEMORECEPTOR; CHRONIC KIDNEY FAILURE; HEART RATE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REFLEX; RENAL REPLACEMENT THERAPY;

ADAPTATION, PHYSIOLOGICAL; CHEMORECEPTOR CELLS; FEMALE; HEART RATE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; REFLEX; RENAL DIALYSIS; SYMPATHETIC NERVOUS SYSTEM;

EID: 79952278839     PISSN: 09492321     EISSN: 2047783X     Source Type: Journal    
DOI: 10.1186/2047-783X-15-S2-83     Document Type: Article

References (19)

1. Wirta O, Pasternack A, Mustonen J, Laippala P: Renal and cardiovascular predictors of 9-year total and sudden cardiac mortality in non-insulin-dependent diabetic subjects. Nephrol Dial Transplant 1997, 12: 2612-7. 10.1093/ndt/12.12.2612
2. Converse RL Jr, Jacobsen TN, Toto RD, Jost CMT, Cosentino F, Fouad-Tarazi F, Victor RG: Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992, 327: 1912-8. 10.1056/NEJM199212313272704
3. Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F, Wieneke GH, van Huffelen AC, Koomans HA: Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 1999, 340: 1321-8. 10.1056/NEJM199904293401704
4. Neumann J, Ligtenberg G, Klein II, Koomans HA, Blankestijn PJ: Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment. Kidney Int 2004, 65: 1568-76. 10.1111/j.1523-1755.2004.00552.x
5. Cashion AK, Hathaway DK, Milstead EJ, Reed L, Gaber AO: Changes in patterns of 24-hr heart rate variability after kidney and kidney-pancreas transplant. Transplantation 1999, 68: 1846-50. 10.1097/00007890-199912270-00005
6. Rubinger D, Sapoznikov D, Pollak A, Popovtzer MM, Luria MH: Heart rate variability during chronic hemodialysis and after renal transplantation: studies in patients without and with systemic amyloidosis. J Am Soc Nephrol 1999, 10: 1972-81.
7. Meyer C, Rana OR, Saygili E, Ozüyaman B, Latz K, Rassaf T, Kelm M, Schauerte P: Hyperoxic chemoreflex sensitivity is impaired in patients with neurocardiogenic syncope. Int J Cardiol 2010, 142: 38-43. 10.1016/j.ijcard.2008.12.081
8. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130: 461-70.
9. Meyer C, Heiss C, Drexhage C, Kehmeier ES, Balzer J, Mühlfeld A, Merx MW, Lauer T, Kühl H, Floege J, Kelm M, Rassaf T: Hemodialysis-induced release of hemoglobin limits nitric oxide bioavailability and impairs vascular function. J Am Coll Cardiol 2010, 55: 454-9. 10.1016/j.jacc.2009.07.068
10. Hennersdorf MG, Hillebrand S, Perings C, Strauer BE: Chemoreflex sensitivity in chronic heart failure patients. Eur J Heart Fail 2001, 3: 679-84. 10.1016/S1388-9842(01)00189-1
11. Hennersdorf MG, Niebch V, Perings C, Strauer BE: Chemoreflex sensitivity as a predictor of arrhythmia relapse in ICD recipients. Int J Cardiol 2002, 86: 169-75. 10.1016/S0167-5273(02)00191-2
12. Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, Dietl KH, Rahn KH: Sympathetic nerve activity in end-stage renal disease. Circulation 2002, 106: 1974-9. 10.1161/01.CIR.0000034043.16664.96
13. Hausberg M, Lang D, Levers A, Suwelack B, Kisters K, Tokmak F, Barenbrock M, Kosch M: Sympathetic nerve activity in renal transplant patients before and after withdrawal of cyclosporine. J Hypertens 2006, 24: 957-64. 10.1097/01.hjh.0000222767.15100.e4
14. Meyer C, Rana OR, Saygili E, Gemein C, Becker M, Nolte KW, Weis J, Schimpf T, Knackstedt C, Mischke K, Hoffmann R, Kelm M, Pauza D, Schauerte P: Augmentation of left ventricular contractility by cardiac sympathetic neural stimulation. Circulation 2010, 121: 1286-94. 10.1161/CIRCULATIONAHA.109.874263
15. Somers VK, Mark AL, Abboud FM: Interaction of baroreceptor and chemoreceptor reflex control of sympathetic nerve activity in normal humans. J Clin Invest 1991, 87: 1953-7. 10.1172/JCI115221
16. Hering D, Zdrojewski Z, Krol E, Kara T, Kucharska W, Somers VK, Rutkowski B, Narkiewicz K: Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure. J Hypertens 2007, 25: 157-61. 10.1097/HJH.0b013e3280102d92
17. Steinberg AA, Mars RL, Goldman DS, Percy RF: Effect of end-stage renal disease on decreased heart rate variability. Am J Cardiol 1998, 82: 1156-8. A10 10.1016/S0002-9149(98)00580-3
18. Tong YQ, Hou HM: Alteration of heart rate variability parameters in nondiabetic hemodialysis patients. Am J Nephrol 2007, 27: 63-9. 10.1159/000099013
19. Tory K, Suveges Z, Horvath E, Bokor E, Sallay P, Berta K, Szabo A, Tulassay T, Reusz GS: Autonomic dysfunction in uremia assessed by heart rate variability. Pediatr Nephrol 2003, 18: 1167-71. 10.1007/s00467-003-1280-4